Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
Sixty-two Mycobacterium tuberculosis isolates were tested for pyrazinamidase activity, and their pyrazinamide susceptibility was determined by the radiometric method. Sequencing of pncA genes in the 23 resistant strains revealed mutations in 16 pyrazinamidase-negative strains, 11 of which had not been previously described. Six isolates containing wild-type pncA might possess alternative resistance mechanisms.
Mestdagh
M
M
Laboratory for Pharmaceutical Biotechnology, FFW, University of Ghent, 9000 Ghent, Belgium.
Fonteyne
P A
PA
Realini
L
L
Rossau
R
R
Jannes
G
G
Mijs
W
W
De Smet
K A
KA
Portaels
F
F
Van den Eeckhout
E
E
D000581:Amidohydrolases / Q000235:genetics / Q000378:metabolism*; D000995:Antitubercular Agents / Q000494:pharmacology*; D018432:Drug Resistance, Multiple; D015971:Gene Expression Regulation, Enzymologic; D009154:Mutation; D009169:Mycobacterium tuberculosis / Q000145:classification / Q000187:drug effects* / Q000201:enzymology* / Q000302:isolation & purification; D011718:Pyrazinamide / Q000494:pharmacology*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D000581:Amidohydrolases; C022490:pyrazinamide deamidase